SEARCH

SEARCH BY CITATION

References

  • 1
    Jassal M, Bishai W. Extensively drug-resistant tuberculosis. Lancet Infect Dis. 2009;9: 1930.
  • 2
    World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec. 2006;81: 430432.
  • 3
    World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 Global report on surveillance and response. Available at: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf (accessed 1 October 2010).
  • 4
    World Health Organization. Antituberculosis drug resistant in the world: report no.4. Geneva, WHO. Available at: http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.394_eng.pdf (accessed 29 March 2009).
  • 5
    Blondal K. Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis. Bull World Health Organ. 2007;85(5): 387390. discussion 391–4.
  • 6
    Chan E, Iseman M. Multi-drug resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis. 2008;21(6): 587595.
  • 7
    Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368(9547): 15751580.
  • 8
    Bonilla CA, Crossa A, Jave H, Mitnick CD, Jamanca RB, Herrera C, Jaramillo E, Asencios L, Mendonza A, Bayona J, Zignol M. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS ONE. 2008;3(8): e2957. doi:10.1371/journal.pone.0002957.
  • 9
    Shah NS, Pratt R, Armstrong L, Robison V, Castro K, Cegielski JP. Extensively drug-resistant tuberculosis in the United States, 1993–2007. JAMA. 2008;300(18): 21532160.
  • 10
    Jeon CY, Hwang SH, Min JH, et al. Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes. Clin Infect Dis. 2008;46(1): 4249.
  • 11
    Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch Gerdes S, Lange C, German TBNET group. Multidrug and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis. 2008;14(11): 17001706.
  • 12
    Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of extensively drug-resistant definition. Eur Respir J. 2007;30(4): 623626.
  • 13
    Mitnick CD, Shin S, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359(6): 563574.
  • 14
    Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, Hoffner SE. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest. 2009;136(2): 420425.
  • 15
    Glasziou P, Bain C, Irwing L, Colditz G. Systematic Reviews in Health Care: A Practical Guide. Cambridge, Cambridge University Press, 2001.
  • 16
    Gandhi NR, Shah NS, Andrews J, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH, Tugela Ferry Care and Research (TF CARES) Collaboration. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181(1): 8086.
  • 17
    Vilariça AS, Gomes C, Pina J. Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis – epidemiology and predictive factors. Rev Port Pneumol. 2008;14(6): 829842.
  • 18
    Abubakar I, Moore J, Drobniewski F, et al. Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. Thorax. 2009;64(6): 512515.
  • 19
    Punga V, Jakubowiak W, Danilova D, Somova TR, Volchenkov GV, Kazionnyy BY, Nemtsova ES, Kiryanova EV, Kourbatova EV. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia. Int J Tuberc Lung Dis. 2009;13(10): 13091312.
  • 20
    Murase Y, Maeda S, Yamada H, Ohkado A, Chikamatsu K, Mizuno K, Kato S, Mitarai S. Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis. 2010;16(6): 948954.
  • 21
    Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J. Extensively drug-resistant tuberculosis in California, 1993–2006. Clin Infect Dis. 2008;47: 450457.
  • 22
    Killmann K, Altraja A. Predictors of poor treatment outcome in highly drug-resistant pulmonary tuberculosis. ERJ Express. 2009;33: 10851094.
  • 23
    Lai CC, Tan CK, Huang YT, Luh KT, Hsueh PR. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000–2006 at a medical center in Taiwan. Clin Infect Dis. 2008;47(7): e5763.
  • 24
    Lai CC, Tan CK, Lin SH, Liao CH, Huang YT, Chou CH, Hsu HL, Wang CY, Lin HI, Hsueh PR. Clinical and genotypic characteristics of extensively drug-resistant and multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis. 2010;29(5): 597600.
  • 25
    Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, Kim EK, Lee KM, Lee SS, Park JS, Koh WJ. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2010;182(1): 113119.
  • 26
    Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis. 2008;12(1): 99104.
  • 27
    Chakraborty N, De C, Bhattacharyya S, Mukherjee A, Santra S, Banerjee D, Sarkar RN, Guha SK. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India. Trans R Soc Trop Med Hyg. 2010;104(3): 195201.
  • 28
    Saleri N, Badoum G, Ouedraogo M, Dembele SM, Nacanabo R, Bonkoungou V, Cirillo D, Pinsi G, Matteelli A. Extensively drug-resistant tuberculosis, Burkina Faso. Emerg Infect Dis. 2010;16(5): 840842.
  • 29
    Masjedi MR, Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, Amiri M, Mansouri D, Velayati AA. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients. Int J Infect Dis. 2010;14(5): e399402.
  • 30
    Sun Z, Chao Y, Zhang X, Zhang J, Li Y, Qiu Y, Liu Y, Nie L, Guo A, Li C. Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China. J Clin Microbiol. 2008;46(12): 40754077.
  • 31
    Chuchottaworn C. Extensively drug-resistant tuberculosis (XDR-TB) in Chest Disease Institute, 1997–2005. J Med Assoc Thai. 2010;93(1): 3437.
  • 32
    Sharma S, George N, Kadhiravan T, Saha PK, Mishra HK, Hanif M. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study. Indian J Med Res. 2009;130(4): 392395.
  • 33
    Shin S, Keshavjee S, Gelmanova IY, et al. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med. 2010;182(3): 426432.
  • 34
    Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, Moll AP, Pillay M, Friedland G, Sturm AW; Tugela Ferry Care and Research Collaboration. Exogenous reinfection as a cause of multidrug resistant and extensively drug-resistant tuberculosis in rural South Africa. J Infect Dis. 2008;198(11): 15821589.
  • 35
    Calver A, Falmer A, Murray M, Strauss OJ, Streicher EM, Hanekom M, Liversage T, Masibi M, van Helden PD, Warren RM, Victor TC. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg Infect Dis. 2010;16(2): 264271.
  • 36
    Fry RS, Khoshnood K, Vdovichenko E, Granskaya J, Sazhin V, Shpakovskaya L, et al. Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. Int J Tuberc Lung Dis. 2005;9(9): 10271033.
  • 37
    Ruslami R, Aarnoutse RE, Alisjahbana B, van der Vem AJ, van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health. 2010;15(11): 12899.
  • 38
    Grandjean L, Moore D. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis. 2008;21(5): 454461.
  • 39
    Huang TS, Kunin C, Lee S, Chen YS, Tu HZ, Liu YC. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995–2003. J Antimicrob Chemother. 2005;56(6): 10581062.
  • 40
    Sotgiu G, Ferrara G, Matteelli A, Richardson MD, Centis R, Ruesch-Gerdes S, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J. 2009;33: 871881.